Gabrail Cancer Center, LLC is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Gabrail Cancer Center, LLC has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.
Sponsors: Amgen.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gabrail Cancer Center, LLC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gabrail Cancer Center, LLC has 2 clinical trials on record, with 1 currently active. Their work covers Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.
Gabrail Cancer Center, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.